Stay updated on Pembrolizumab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in ES-SCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    A new site revision label, v3.7.0, was added while the previous label, v3.6.6, was removed, indicating an internal build update rather than changes to the study record.
    Difference
    0.0%
    Check dated 2026-09-15T22:27:50.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a maintenance/update to the page's underlying system rather than changes to the study content.
    Difference
    0.0%
    Check dated 2026-09-01T18:14:00.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A 2023 U.S. NIH Grant/Contract funding line was added to the study's funding disclosures, updating the source of support for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:00:54.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Tumor size change definitions were added to specify that change is the best percent change from baseline in the sum of target lesions, assessed by centralized review (BICR) per RECIST 1.1, and the mean of this metric is presented. The EORTC QLQ-C30 quality-of-life description was expanded to explain scoring and interpretation (7-point scale and 0–100 normalization), and the Plain Language Summary was removed.
    Difference
    0.3%
    Check dated 2026-08-18T15:59:27.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The page's revision stamp changed from v3.6.4 to v3.6.5, indicating a newer build of the page. This update reflects an internal release/version update rather than content changes.
    Difference
    0.0%
    Check dated 2026-08-11T14:36:38.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    Revision: v3.6.4 is now shown on the page, replacing Revision: v3.6.3. This indicates a new build/version update and does not alter study details, data, or visible layout.
    Difference
    0.0%
    Check dated 2026-07-28T05:31:06.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in ES-SCLC Clinical Trial page.